Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
There is currently no readily available pharmacologic intervention for suicidal ideation, a
true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial
low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant
depression, for patients who present to the ED with suicidal ideation.